CD24 and breast cancer: Moreover, immune-mediated induction of EMT in epithelial breast cancer cells resulted in a mesenchymal population with the breast cancer CSC immunophenotype CD24−/loCD44+ as well as the capacity to repopulate the malignancy after transplantation of low cell numbers.